Temozolomide and Radiation Therapy With or Without Cediranib Maleate in Treating Patients With Newly Diagnosed Glioblastoma
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Temozolomide
Related studies linked through entity extraction aliases.
Temozolomide, Cixutumumab, and Combination Chemotherapy in Treating Patients With Metastatic Rhabdomyosarcoma
- Status
- COMPLETED
- Phase
- PHASE2
A Study of ABT-888 in Combination With Temozolomide for Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Temozolomide Plus Bevacizumab in Patients With Metastatic Melanoma Involving the Central Nervous System
- Status
- COMPLETED
- Phase
- PHASE2
Dose Escalation Radiotherapy With Modulation of Intensity and Integrated Boost (SIB-IMRT) in the Treatment of Glioblastomas in Adults
- Status
- COMPLETED
- Phase
- PHASE1
Radiation Therapy and Temsirolimus or Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma
- Status
- COMPLETED
- Phase
- PHASE2
Whole Brain Radiotherapy With or Without Temozolomide at Daily Fixed-dose for Brain Metastases Treatment
- Status
- COMPLETED
- Phase
- PHASE2
Intercontinental Multidisciplinary Registry and Treatment Optimization Study for Choroid Plexus Tumors
- Status
- TERMINATED
- Phase
- PHASE3
Bevacizumab, Temozolomide, and External Beam Radiation Therapy as First-Line Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme or Gliosarcoma
- Status
- COMPLETED
- Phase
- PHASE2
ABT-888 and Temozolomide for Metastatic Breast Cancer and BRCA1/2 Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Temozolomide and Sunitinib Malate in Treating Patients With Stage III or Stage IV Malignant Melanoma
- Status
- COMPLETED
- Phase
- PHASE1
Avastin/Radiation (XRT)/Temozolomide (Temodar) Followed by Avastin/Temodar/Topotecan for Glioblastoma
- Status
- COMPLETED
- Phase
- PHASE2
A Phase I Study of ABT-888, an Oral Inhibitor of Poly(ADP-ribose) Polymerase and Temozolomide in Children With Recurrent/Refractory CNS Tumors
- Status
- COMPLETED
- Phase
- PHASE1
A Study of Vincristine, Escalating Doses of Irinotecan, Temozolomide and Bevacizumab (Vit-b) in Pediatric and Adolescent Patients With Recurrent or Refractory Solid Tumors of Non-hematopoietic Origin
- Status
- COMPLETED
- Phase
- PHASE1
Presurgery Bortezomib for Recurrent Malignant Gliomas Followed by Postop Bortezomib & Temozolomide
- Status
- COMPLETED
- Phase
- PHASE2
Avastin/Temozolomide/Irinotecan for Unresectable/Multifocal Glioblastoma Multiforme
- Status
- COMPLETED
- Phase
- PHASE2
Radiation Therapy With or Without Temozolomide in Treating Patients With Low-Grade Glioma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Open Label Trial to Explore Safety of Combining Afatinib (BIBW 2992) and Radiotherapy With or Without Temozolomide in Newly Diagnosed Glioblastoma Multiform
- Status
- COMPLETED
- Phase
- PHASE1
Cisplatin, Temozolomide, Abraxane, With Interleukin-2 and Interferon for Metastatic Melanoma
- Status
- COMPLETED
- Phase
- PHASE1
A Study of Avastin (Bevacizumab) and Irinotecan Versus Temozolomide Radiochemistry in Patients With Glioblastoma
- Status
- COMPLETED
- Phase
- PHASE2